CXCL8 and neoplasm: Neoplastic cells are able to produce and release CXCL8, which in turn acts on the tumor microenvironment, promoting angiogenesis, epithelial–mesenchymal transition, increased endothelial cell permeability, suppressing anti-tumor immunity, and eventually favoring clone motility and invasiveness.